BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16306003)

  • 1. Content analysis and stability evaluation of selected commercial preparations of St. John's wort.
    Shah AK; Avery BA; Wyandt CM
    Drug Dev Ind Pharm; 2005 Oct; 31(9):907-16. PubMed ID: 16306003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the hypericin and pseudohypericin content of commercially available St John's Wort preparations.
    Draves AH; Walker SE
    Can J Clin Pharmacol; 2003; 10(3):114-8. PubMed ID: 14506510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of total hypericins in St. John's wort and herbal medicinal products.
    Anyzewska M; Kowalczuk A; Łozak A; Jabłczyńska R; Fijałek Z
    Acta Pol Pharm; 2010; 67(6):586-92. PubMed ID: 21229872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high-performance liquid chromatography with electrochemical detection for the determination of total hypericin in extracts of St. John's Wort.
    Rückert U; Eggenreich K; Likussar W; Wintersteiger R; Michelitsch A
    Phytochem Anal; 2006; 17(3):162-7. PubMed ID: 16749423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of hypericin and pseudohypericin in pharmaceutical preparations by liquid chromatography with fluorescence detection.
    Draves AH; Walker SE
    J Chromatogr B Biomed Sci Appl; 2000 Nov; 749(1):57-66. PubMed ID: 11129079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of St. John's wort from different Italian regions.
    Pietta P; Gardana C; Pietta A
    Farmaco; 2001; 56(5-7):491-6. PubMed ID: 11482784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TESTING PHARMACEUTICAL RELEASE OF ACTIVE SUBSTANCES FROM MEDICINAL PRODUCTS CONTAINING ST. JOHN'S WORT.
    Sakowska J; Anyzewska M; Łozak A; Kowalczuk A; Jabłczyńska R
    Acta Pol Pharm; 2016; 73(2):395-401. PubMed ID: 27180432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining hyperforin and hypericin content in eight brands of St. John's wort.
    de los Reyes GC; Koda RT
    Am J Health Syst Pharm; 2002 Mar; 59(6):545-7. PubMed ID: 11908248
    [No Abstract]   [Full Text] [Related]  

  • 9. [Quantitative analysis of active substances in St. John's wort (Hypericum perforatum L.) by the high performance liquid chromatography method].
    Kazlauskas S; Bagdonaite E
    Medicina (Kaunas); 2004; 40(10):975-81. PubMed ID: 15516821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinic at the health food store? Employee recommendations and product analysis.
    Glisson JK; Rogers HE; Abourashed EA; Ogletree R; Hufford CD; Khan I
    Pharmacotherapy; 2003 Jan; 23(1):64-72. PubMed ID: 12523461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Batch-to-batch reproducibility of St. John's wort preparations.
    Wurglics M; Westerhoff K; Kaunzinger A; Wilke A; Baumeister A; Dressman J; Schubert-Zsilovecz M
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S152-6. PubMed ID: 11518067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Flavonoid and dianthranoid levels of the St.-John's-wort flowering tops].
    Girzu-Amblard M; Carnat A; Fraisse D; Carnat AP; Lamaison JL
    Ann Pharm Fr; 2000 Oct; 58(5):341-5. PubMed ID: 11060411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High performance liquid chromatographic analysis of St. John's wort with photodiode array detection.
    Li W; Fitzloff JF
    J Chromatogr B Biomed Sci Appl; 2001 Dec; 765(1):99-105. PubMed ID: 11817315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a simple, rapid and reproducible HPLC assay for the simultaneous determination of hypericins and stabilized hyperforin in commercial St. John's wort preparations.
    de los Reyes GC; Koda RT
    J Pharm Biomed Anal; 2001 Dec; 26(5-6):959-65. PubMed ID: 11600308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of chemical stability of St. John's wort commercial extract and some preparations.
    Bilia AR; Bergonzi MC; Morgenni F; Mazzi G; Vincieri FF
    Int J Pharm; 2001 Feb; 213(1-2):199-208. PubMed ID: 11165108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of the predominant hyperforins and hypericins in St. John's Wort (Hypericum perforatum L.) by liquid chromatography.
    Gray DE; Rottinghaus GE; Garrett HE; Pallardy SG; Gray DE; Rottinghaus GE; Garrett HE; Pallardy SG
    J AOAC Int; 2000; 83(4):944-9. PubMed ID: 10995119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of methods for determination of naphthodianthrones and flavonoids in St. John's wort.
    Williams FB; Sander LC; Wise SA; Girard J
    J Chromatogr A; 2006 May; 1115(1-2):93-102. PubMed ID: 16554056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. St. John's wort.
    Lawvere S; Mahoney MC
    Am Fam Physician; 2005 Dec; 72(11):2249-54. PubMed ID: 16342849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in the content of the constituents of Hypericum perforatum L. and some commercial extracts.
    Bergonzi MC; Bilia AR; Gallori S; Guerrini D; Vincieri FF
    Drug Dev Ind Pharm; 2001 Jul; 27(6):491-7. PubMed ID: 11548855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of the major constituents of St John's wort with HPLC-ESI-MS.
    Chandrasekera DH; Welham KJ; Ashton D; Middleton R; Heinrich M
    J Pharm Pharmacol; 2005 Dec; 57(12):1645-52. PubMed ID: 16354409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.